CEACAM5 and adenocarcinoma: Sub-analysis stratified by histology shows that in adenocarcinoma patients, the patterns in 5-year RFS and OS across the three CEA trajectory groups are highly consistent with those observed in the overall population (Supplementary Figures S5a, b).